Huang James 4
4 · CASI Pharmaceuticals, Inc. · Filed Sep 8, 2022
Insider Transaction Report
Form 4
Huang James
Director
Transactions
- Purchase
Common Stock
2022-09-07$4.00/sh+3,111$12,433→ 338,217 total(indirect: See Footnote) - Purchase
Common Stock
2022-09-06$3.89/sh+19,162$74,601→ 335,106 total(indirect: See Footnote) - Purchase
Common Stock
2022-09-08$4.28/sh+33,300$142,627→ 371,517 total(indirect: See Footnote)
Holdings
- 191
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Represents securities held by Panacea Opportunity Fund I, L.P., over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.9401 to $4.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.115 to $4.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.